Navigation Links
Sao Paulo Hosts Strong Second Year for South American Pharma Events

MAARSSEN, Netherlands, Oct. 12 /PRNewswire/ -- Held in the heart of Brasil's pharmaceutical industry, Sao Paulo, late August's CPhI South America and P-MEC South America pharma ingredients and production technology events built strongly on their 2008 debuts.

At just over 4,900, visitor numbers for the 150+ exhibitors at the Transamerica Expo Center were almost 10% ahead of the 2008 launch event in Rio, with a major international presence. Organisers UBM International Media say that over 70% of space for the 2010 events has already been sold.

Led by Brazil, the markets of Latin and Central America are joining China and India as regions of dramatic future opportunities for pharma-related services.

Eliane van Doorn, UBM International Media's Pharma Portfolio Group Director, commented:

"Against the challenging business background since their launch last year, the 2009 events clearly delivered for both exhibitors and visitors, laying deep foundations for next year!"

Providing coverage across the pharma ingredients, contract services and production equipment and technology sectors, co-location of CPhI and P-MEC is a proven formula that ensures a high level of networking and business opportunities in a single event visit.

Key Brazilian pharma trade organisations supporting the 2009 exhibitions included ABIQUIF, ABRIFAR ABIMIP, ABIFINA, Alanac, ANVISA, ASSOCIQUIM, CRF-SP, Interfarma, Pro-Genericos, and Sindusfarma.

Alongside the exhibitions, the wide-ranging conference programme included the ISPE Brazil Life Sciences Congress; the 1st CRF-SP Clinical Research Seminar; the 2nd. Latin American Pharma Business Forum; the 1st. Sindusfarma Symposium of Pharmaceutical Management and the BioPh-Biosolutions for Pharma conference on The Brazil Regulatory Scenario.

Returning after the successful 2008 debut in Rio, the buyers' and sellers' "Match and Meet" networking sessions -- on pharmaceutical ingredients, contract services and licensing -- underlined the networking depth of the event.

"The good feedback on the quality of visitors and business networking value clearly reflects the perceived importance of the event -- and exceeding last year's visitor numbers was a great bonus," said Eliane van Doorn. "With continuing market growth across South and Latin America, and the quickening pace of international partnerships as the standout themes, we are very positive for 2010," she added.

For 2010, CPhI South America and P-MEC South America move to Argentina's La Rural - Hall Ocre facility in Buenos Aires, on 17 - 19 August. Next year will also mark the full debuts of ICSE South America and BioPh South America. In 2011, the fourth edition of the events will return to Sao Paulo.

UBM International Media's annual sister events for the pharma ingredients and services sector include Japan (April); China (June); Worldwide (Europe - October) and India (December).

SOURCE United Business Media

SOURCE United Business Media
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
2. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
3. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
4. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
5. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
6. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
7. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
8. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
9. Results and Additional Analyses From Study Show That Cortheras Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
10. Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
11. SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015   VolitionRx Limited (NYSE MKT: ... tests for a broad range of cancer types and other ... Micro Conference, which will be held December 1 - 3 in ... VolitionRx will be David Kratochvil , Chief Financial Officer ... Investor Relations. ® blood-based tests for colorectal ...
(Date:11/30/2015)... Nov. 30, 2015  Precision Image Analysis Inc. ... pleased to announce a dramatic expansion of its ... Building on its ISO-9001:2008 certification for its Quality ... Core Lab protocols and procedures. This expansion enables ... activities.  Their Core Lab services include design and ...
(Date:11/30/2015)... BOSTON , November 30, 2015 ... medicines directed at up to 10 G protein-coupled receptor ... PFE ) to research and develop potential new medicines ... targets across multiple therapeutic areas. --> Heptares ... development company and wholly-owned subsidiary of Sosei Group Corporation ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... 30, 2015 , ... Holcomb – Kreithen Plastic Surgery ... practices in Florida, is proud to announce that Dr. Joshua Kreithen, one of ... Inc., a Johnson & Johnson Company. , Ethicon is a global medical device ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” ... three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... , ... The successful filing of an Investigational New Drug application (IND) is ... this key industry segment, Regis Technologies has decided to sponsor and participate in an ... EST. , Federal law does not allow new drugs to cross state lines until ...
(Date:11/30/2015)... ... 2015 , ... Vasont Systems, a top component content management ... unites with Syncro Soft’s latest software update, oXygen XML editor Version 17.1. Users ... latest release of oXygen® XML editor and the Vasont® CCMS. , The ...
Breaking Medicine News(10 mins):